HK Stock MarketDetailed Quotes
01011 NT PHARMA
- 0.305
- -0.015-4.69%
Market Closed Nov 8 16:08 CST
80.55MMarket Cap-535P/E (TTM)
0.310High0.300Low123.25KVolume0.310Open0.320Pre Close37.43KTurnover0.05%Turnover RatioLossP/E (Static)264.09MShares1.40052wk High-0.21P/B80.55MFloat Cap0.17052wk Low--Dividend TTM264.09MShs Float42.200Historical High--Dividend LFY3.13%Amplitude0.170Historical Low0.303Avg Price10000Lot Size--Div YieldTTM--Div Yield LFY
NT PHARMA Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -133.18%-126.61M | ---- | 63.50%-54.3M | ---- | 59.68%-148.75M | ---- | 36.77%-368.93M | ---- | 36.85%-583.47M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 41.67%-14K | ---- | 89.96%-24K | ---- | 91.57%-239K | ---- | -50.48%-2.84M | ---- | 10.37%-1.88M |
| Attributable subsidiary (profit) loss | ---- | -311.41%-37.04M | ---- | 73.90%-9M | ---- | -431,025.00%-34.49M | ---- | -129.63%-8K | ---- | -98.63%27K |
| Impairment and provisions: | ---- | -82.93%4.18M | ---- | -53.84%24.48M | ---- | -50.80%53.04M | ---- | -76.46%107.79M | ---- | -25.27%457.97M |
| -Impairment of property, plant and equipment (reversal) | ---- | -82.05%14K | ---- | --78K | ---- | ---- | ---- | -200.00%-10.98M | ---- | --10.98M |
| -Impairmen of inventory (reversal) | ---- | ---- | ---- | 257.45%1.68M | ---- | 19.90%470K | ---- | -83.40%392K | ---- | -85.35%2.36M |
| -Impairment of trade receivables (reversal) | ---- | -64.00%4.17M | ---- | -25.58%11.57M | ---- | 145.86%15.55M | ---- | -95.29%6.32M | ---- | -69.04%134.34M |
| -Other impairments and provisions | ---- | ---- | ---- | -69.87%11.16M | ---- | -66.96%37.02M | ---- | -63.89%112.06M | ---- | 90.59%310.29M |
| Revaluation surplus: | ---- | 64.25%-2.05M | ---- | -178.34%-5.75M | ---- | -34.89%7.34M | ---- | -62.27%11.27M | ---- | -90.21%29.85M |
| -Other fair value changes | ---- | 64.25%-2.05M | ---- | -178.34%-5.75M | ---- | -34.89%7.34M | ---- | -62.27%11.27M | ---- | -90.21%29.85M |
| Asset sale loss (gain): | ---- | -2,063.42%-12.29M | ---- | 101.27%626K | ---- | -250.48%-49.47M | ---- | 5,077.01%32.87M | ---- | 112.37%635K |
| -Loss (gain) from sale of subsidiary company | ---- | -2,060.38%-12.27M | ---- | 101.60%626K | ---- | -219.31%-39.03M | ---- | --32.71M | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---19K | ---- | ---- | ---- | 1,335.00%2.3M | ---- | -74.80%160K | ---- | 112.37%635K |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---12.73M | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | -72.09%5.88M | ---- | -50.13%21.07M | ---- | 73.17%42.25M | ---- | -21.63%24.4M | ---- | -12.67%31.13M |
| -Amortization of intangible assets | ---- | -44.06%1.1M | ---- | -0.10%1.97M | ---- | -3.57%1.97M | ---- | -69.39%2.05M | ---- | -42.55%6.68M |
| -Other depreciation and amortization | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%991K |
| Financial expense | ---- | -28.87%51.03M | ---- | -19.15%71.73M | ---- | 2.53%88.73M | ---- | -17.09%86.54M | ---- | 28.77%104.38M |
| Special items | ---- | 14,477.82%86.74M | ---- | 287.70%595K | ---- | 11.45%-317K | ---- | -104.80%-358K | ---- | -9.66%7.46M |
| Operating profit before the change of operating capital | ---- | -161.05%-30.18M | ---- | 217.94%49.44M | ---- | 61.64%-41.92M | ---- | -337.03%-109.27M | ---- | -61.24%46.1M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -112.71%-2.53M | ---- | 483.27%19.88M | ---- | -176.50%-5.19M | ---- | -16.68%6.78M | ---- | 92.39%8.14M |
| Accounts receivable (increase)decrease | ---- | 309.70%67.33M | ---- | -504.32%-32.11M | ---- | -70.08%7.94M | ---- | 865.41%26.54M | ---- | 102.17%2.75M |
| Accounts payable increase (decrease) | ---- | 1,722.91%16.72M | ---- | 98.91%-1.03M | ---- | -192.86%-94.81M | ---- | 1,373.89%102.1M | ---- | 93.11%-8.02M |
| Special items for working capital changes | ---- | ---- | ---- | 290.00%1.06M | ---- | ---560K | ---- | ---- | ---- | ---- |
| Cash from business operations | ---- | 37.81%51.33M | ---- | 127.69%37.25M | ---- | -614.41%-134.54M | ---- | -46.60%26.15M | ---- | 140.89%48.97M |
| China income tax paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 104.14%50K | ---- | 72.74%-1.21M |
| Other taxs | ---- | 17.60%-857K | ---- | -30.65%-1.04M | ---- | ---796K | ---- | ---- | ---- | ---- |
| Special items of business | -148.66%-5.74M | ---- | -52.57%11.8M | ---- | -23.48%24.87M | ---- | 15.51%32.5M | ---- | 134.38%28.14M | ---- |
| Net cash from operations | -148.66%-5.74M | 39.40%50.48M | -52.57%11.8M | 126.76%36.21M | -23.48%24.87M | -616.47%-135.34M | 15.51%32.5M | -45.14%26.2M | 134.38%28.14M | 138.46%47.77M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -41.67%14K | ---- | -89.96%24K | ---- | -91.57%239K | ---- | 50.48%2.84M | ---- | -10.37%1.88M |
| Decrease in deposits (increase) | ---- | ---- | ---- | ---- | ---- | -56.94%25.52M | ---- | 226.67%59.27M | ---- | -272.21%-46.79M |
| Sale of fixed assets | ---- | --159K | ---- | ---- | ---- | --3.56M | ---- | ---- | ---- | -98.92%4K |
| Purchase of fixed assets | ---- | -138.83%-10.73M | ---- | -595.67%-4.49M | ---- | 97.29%-646K | ---- | 33.83%-23.84M | ---- | -202.07%-36.03M |
| Selling intangible assets | ---- | ---- | ---- | ---- | ---- | --29M | ---- | ---- | ---- | ---- |
| Purchase of intangible assets | ---- | ---2.16M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 77.65%-51.17M |
| Sale of subsidiaries | ---- | -102.19%-197K | ---- | -98.41%9M | ---- | 1.39%566.12M | ---- | --558.37M | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | -35,368.51%-364.97M | ---- | ---1.03M | ---- | ---- |
| Other items in the investment business | 93.28%-129K | ---9.22M | 7.74%-1.92M | ---- | -102.00%-2.08M | ---1M | 172.84%104.3M | ---- | --38.23M | -3,638.60%-74.77M |
| Net cash from investment operations | 93.28%-129K | -588.74%-22.14M | 7.74%-1.92M | -98.24%4.53M | -102.00%-2.08M | -56.71%257.81M | 172.84%104.3M | 387.90%595.6M | 141.23%38.23M | -44.42%-206.88M |
| Net cash before financing | -159.43%-5.87M | -30.45%28.34M | -56.66%9.88M | -66.74%40.74M | -83.34%22.79M | -80.30%122.48M | 106.14%136.8M | 490.80%621.81M | 138.02%66.36M | 40.51%-159.11M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | -49.70%14.86M | ---- | -59.68%29.54M | ---- | -93.72%73.27M | ---- | 13.94%1.17B | ---- | -33.72%1.02B |
| Refund | ---- | 88.14%-8.57M | ---- | 51.85%-72.28M | ---- | 91.31%-150.13M | ---- | -64.87%-1.73B | ---- | 12.59%-1.05B |
| Issuing shares | ---- | 364.77%9.39M | ---- | --2.02M | ---- | ---- | ---- | ---- | ---- | --200.07M |
| Issuance of bonds | ---- | -86.50%3.22M | ---- | 139.65%23.84M | ---- | -29.88%9.95M | ---- | -69.77%14.19M | ---- | --46.94M |
| Interest paid - financing | ---- | -6.84%-18.77M | ---- | 59.01%-17.57M | ---- | 34.44%-42.86M | ---- | 30.55%-65.37M | ---- | -52.48%-94.13M |
| Issuance expenses and redemption of securities expenses | ---- | -172.63%-28.15M | ---- | 17.99%-10.33M | ---- | -22.76%-12.59M | ---- | 60.69%-10.26M | ---- | ---26.1M |
| Other items of the financing business | 150.88%4.27M | ---- | 68.41%-8.4M | ---- | 81.65%-26.59M | ---- | -94.15%-144.9M | ---- | -26,365.60%-74.63M | 88.10%-1.05M |
| Net cash from financing operations | 150.88%4.27M | 37.93%-28.97M | 68.41%-8.4M | 62.60%-46.68M | 81.65%-26.59M | 80.01%-124.8M | -94.15%-144.9M | -715.79%-624.25M | -152.02%-74.63M | -53.71%101.37M |
| Effect of rate | 26.22%5.87M | -93.12%240K | -58.87%4.65M | 3.62%3.49M | 89.06%11.3M | 118.78%3.37M | -55.00%5.98M | -864.64%-17.92M | -33.28%13.29M | 82.54%-1.86M |
| Net Cash | -208.05%-1.6M | 89.29%-636K | 138.88%1.48M | -155.97%-5.94M | 53.10%-3.8M | 4.92%-2.32M | 2.01%-8.1M | 95.78%-2.44M | 73.41%-8.27M | -19.21%-57.74M |
| Begining period cash | -74.37%1.52M | -56.10%1.92M | -37.19%5.93M | 31.56%4.36M | 22.73%9.44M | -88.24%3.32M | -72.71%7.69M | -67.88%28.2M | -67.88%28.2M | -40.22%87.79M |
| Cash at the end | -51.97%5.79M | -20.67%1.52M | -28.84%12.06M | -56.10%1.92M | 204.29%16.95M | -44.31%4.36M | -83.23%5.57M | -72.21%7.84M | -56.64%33.21M | -67.88%28.2M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Auditor | -- | -- | -- | -- | -- | -- | -- | Guofu Haohua (Hong Kong) Certified Public Accountants Limited | -- | Guofu Haohua (Hong Kong) Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data